Interest Income Expense - Pharmaniaga Bhd (KLSE:PHARMA) - Alpha Spread
P

Pharmaniaga Bhd
KLSE:PHARMA

Watchlist Manager
Pharmaniaga Bhd
KLSE:PHARMA
Watchlist
Price: 0.395 MYR 1.28%
Market Cap: 569.3m MYR
Have any thoughts about
Pharmaniaga Bhd?
Write Note

Pharmaniaga Bhd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pharmaniaga Bhd
Interest Income Expense Peer Comparison

Comparables:
U
UMC

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
P
Pharmaniaga Bhd
KLSE:PHARMA
Interest Income Expense
-myr66.4m
CAGR 3-Years
-33%
CAGR 5-Years
-11%
CAGR 10-Years
-18%
U
UMediC Group Bhd
KLSE:UMC
Interest Income Expense
-myr228.7k
CAGR 3-Years
17%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Pharmaniaga Bhd's Interest Income Expense?
Interest Income Expense
-66.4m MYR

Based on the financial report for Jun 30, 2024, Pharmaniaga Bhd's Interest Income Expense amounts to -66.4m MYR.

What is Pharmaniaga Bhd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-18%

Over the last year, the Interest Income Expense growth was -32%. The average annual Interest Income Expense growth rates for Pharmaniaga Bhd have been -33% over the past three years , -11% over the past five years , and -18% over the past ten years .

Back to Top